Clinical Trials Logo

Insulinemic Response clinical trials

View clinical trials related to Insulinemic Response.

Filter by:
  • None
  • Page 1

NCT ID: NCT03493022 Completed - Glycemic Response Clinical Trials

Glycemic and Insulinemic Impact of a Test Granola 2 Versus a Control Granola

Start date: August 25, 2017
Phase: N/A
Study type: Interventional

The objectives of this study are to examine the blood glucose and serum insulin response elicited by servings of Test Granola and Control Granola containing equal amounts of available carbohydrate over a 3 h time period. In addition, the subjective hunger response to these foods will be measured over 3 h.

NCT ID: NCT03491514 Completed - Glycemic Response Clinical Trials

Glycemic and Insulinemic Impact of a Test Granola 3 Versus a Control Granola

Start date: January 17, 2018
Phase: N/A
Study type: Interventional

The objectives of this study are to examine the blood glucose and serum insulin response elicited by servings of Test Granola and Control Granola containing equal amounts of available carbohydrate over a 3 h time period. In addition, the subjective hunger response to these foods will be measured over 3 h.

NCT ID: NCT03298529 Completed - Healthy Subjects Clinical Trials

Glycemic Index of Traditional Egg Pasta

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

The glycemic index (GI) compares the plasma glucose response to a specific amount of carbohydrates with the response induced by the same amount of carbohydrates from a standard carbohydrate source, pure glucose in our case. The GI is defined as the incremental area under the curve (iAUC) for blood glucose after consumption of a test food divided by the iAUC of a reference food containing the same amount of carbohydrates. GI is based on the physiologic functions of food carbohydrates rather than on their chemical structure, allowing to a more accurate classification. Several studies found that the regular consumption of low glycemic meals reduces the risk of developing diabetes, insulin-resistance, cardiovascular and neoplastic diseases. GI was originally developed for insulin-resistant subjects. The maintenance of stable blood glucose levels is a challenge for people with diabetes and pre-diabetes and is also beneficial for the general population, as reported by several studies. Low-GI diets have been shown to: - stabilize blood sugar levels - improve body weight - better control appetite - improve memory - reduce the risk of cardiovascular diseases - reduce the risk of some forms of cancer According to Walter Willet, nutrition researcher at the Harvard School of Public Health, an excess of sugars and refined starches stimulates insulin hypersecretion, hunger pangs and frequent snacking, slowing down lipid metabolism and making people physically less active. This project aims to evaluate the glycemic index of five different types of pasta with the same format, named "Fettuccine", but with different composition (the pasta format is related to GI variations). The different types of pasta vary for flour and egg composition. However, having the same format, the GI will change only in response to the percentage content of the ingredients used to produce pasta. In particular, the aim is to measure egg's effect, distinct in yolk and white, on the glycemic and insulin response of healthy subjects.

NCT ID: NCT01528631 Completed - Clinical trials for Insulinemic Response

The Effects of D-Fagomine on Glycaemic Response to Sucrose in Men

Start date: February 2012
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effect of D-fagomine on glycaemic response to sucrose in men.